Which feeding tube is best after esophageal cancer surgery?
NCT ID NCT06192212
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 577 patients who had surgery for esophageal cancer. Researchers compared two ways of giving nutrition after surgery: feeding through a tube placed directly into the small intestine (jejunostomy) versus a tube through the nose into the stomach (nasoenteric). The goal was to see if one method leads to fewer complications like pneumonia or leaks. The study is complete, and results may help doctors choose the best feeding method for future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
jejunostomy feeding vs. nasoenteric tube feeding
What this could lead to
If one feeding method proves better, it could become the standard approach to reduce complications after esophageal cancer surgery.
What could go wrong
This is an observational study, not a randomized trial, so results may not prove cause and effect. Differences in patient care could influence outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Army Medical Center of the People's Liberation Army
Chongqing, Chongqing Municipality, 400042, China